Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States
- PMID: 38954841
- PMCID: PMC11630524
- DOI: 10.1093/jnci/djae159
Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States
Abstract
Background: Immunosuppressed individuals have elevated risk of virus-related cancers. Identifying cancers with elevated risk in people with HIV and solid organ transplant recipients, 2 immunosuppressed populations, may help identify novel etiologic relationships with infectious agents.
Methods: We used 2 linkages of population-based cancer registries with HIV and transplant registries in the United States. Cancer entities were systematically classified according to site and histology codes. Standardized incidence ratios were used to compare risk in people with HIV and solid organ transplant recipients with the general population. For selected cancer entities, incidence rate ratios were calculated for indicators of immunosuppression within each population.
Results: We identified 38 047 cancer cases in solid organ transplant recipients and 53 592 in people with HIV, yielding overall standardized incidence ratios of 1.66 (95% confidence interval [CI] = 1.65 to 1.68) and 1.49 (95% CI = 1.47 to 1.50), respectively. A total of 43 cancer entities met selection criteria, including conjunctival squamous cell carcinoma (people with HIV standardized incidence ratio = 7.1, 95% CI = 5.5 to 9.2; solid organ transplant recipients standardized incidence ratio = 9.4, 95% CI = 6.8 to 12.6). Sebaceous adenocarcinoma was elevated in solid organ transplant recipients (standardized incidence ratio = 16.2, 95% CI = 14.0 to 18.6) and, among solid organ transplant recipients, associated with greater risk in lung and heart transplant recipients compared with recipients of other organs (incidence rate ratio = 2.3, 95% CI = 1.7 to 3.2). Salivary gland tumors, malignant fibrous histiocytoma, and intrahepatic cholangiocarcinoma showed elevated risk in solid organ transplant recipients (standardized incidence ratio = 3.9, 4.7, and 3.2, respectively) but not in people with HIV. However, risks for these cancers were elevated following an AIDS diagnosis among people with HIV (incidence rate ratio = 2.4, 4.3, and 2.0, respectively).
Conclusions: Elevated standardized incidence ratios among solid organ transplant recipients and people with HIV, and associations with immunosuppression within these populations, suggest novel infectious causes for several cancers including conjunctival squamous cell carcinoma, sebaceous adenocarcinoma, salivary gland tumors, malignant fibrous histiocytoma, and intrahepatic cholangiocarcinoma.
Published by Oxford University Press 2024.
Conflict of interest statement
None declared.
Comment in
-
Expanding the list of cancers recognized to be caused by infectious agents.J Natl Cancer Inst. 2024 Dec 1;116(12):1875-1877. doi: 10.1093/jnci/djae185. J Natl Cancer Inst. 2024. PMID: 39172647 No abstract available.
References
MeSH terms
Grants and funding
- 27307C0011/ES/NIEHS NIH HHS/United States
- U62 PS004011/PS/NCHHSTP CDC HHS/United States
- HHSN261201800013C/CA/NCI NIH HHS/United States
- N01 PC035137/CA/NCI NIH HHS/United States
- HHSN261201000035I/CA/NCI NIH HHS/United States
- 75N92021D00009/HL/NHLBI NIH HHS/United States
- U62 PS001005/PS/NCHHSTP CDC HHS/United States
- HHSN261201800002B/CA/NCI NIH HHS/United States
- 75N98021D00006/OD/NIH HHS/United States
- HHSN261201000037C/CA/NCI NIH HHS/United States
- 27305C0011/ES/NIEHS NIH HHS/United States
- 75N96021D00006/ES/NIEHS NIH HHS/United States
- HHSN261201800004C/CA/NCI NIH HHS/United States
- N01 PC035143/CA/NCI NIH HHS/United States
- U58 DP003875/DP/NCCDPHP CDC HHS/United States
- 75N97021D00006/LM/NLM NIH HHS/United States
- HHSN261201000036C/CA/NCI NIH HHS/United States
- U62 PS003960/PS/NCHHSTP CDC HHS/United States
- HHSN261201800014C/CA/NCI NIH HHS/United States
- HHSN261201800016C/CA/NCI NIH HHS/United States
- N01 PC035139/CA/NCI NIH HHS/United States
- 75N99021D00009/OF/ORFDO NIH HHS/United States
- U58 DP000807/DP/NCCDPHP CDC HHS/United States
- 27398C0011/ES/NIEHS NIH HHS/United States
- HHSN261201800016I/CA/NCI NIH HHS/United States
- U01 DP006302/DP/NCCDPHP CDC HHS/United States
- U58 DP003933/DP/NCCDPHP CDC HHS/United States
- U58 DP000848/DP/NCCDPHP CDC HHS/United States
- HHSN261201800012C/CA/NCI NIH HHS/United States
- 75N90021D00009/CL/CLC NIH HHS/United States
- HHSN261201000035C/PC/NCI NIH HHS/United States
- HHSN261201000034C/CA/NCI NIH HHS/United States
- U58 DP003921/DP/NCCDPHP CDC HHS/United States
- 75N92021D00006/HL/NHLBI NIH HHS/United States
- HH/HHS/United States
- HHSN261201800014I/CA/NCI NIH HHS/United States
- U62 PS004001/PS/NCHHSTP CDC HHS/United States
- HHSN261201800012I/CA/NCI NIH HHS/United States
- 75N96021D00009/ES/NIEHS NIH HHS/United States
- HHSN261201800002C/CA/NCI NIH HHS/United States
- HHSN261201800013I/CA/NCI NIH HHS/United States
- HHSN261201800006I/CA/NCI NIH HHS/United States
- U58 DP000824/DP/NCCDPHP CDC HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
